Reclast (zoledronic acid)
Title: Reclast (zoledronic acid)Category: MedicationsCreated: 1/3/2008 12:00:00 AMLast Editorial Review: 9/13/2016 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - September 13, 2016 Category: Rheumatology Source Type: news
Osteoporosis Treatment Alternatives To Bisphosphonates
Big Pharma employs a lot of very serious spin-doctors. I’ll give you a good example.
Bisphosphonates For Osteoporosis?
A new study just came out on bisphosphonate drugs. These are the most commonly prescribed drugs for osteoporosis. They’re worth about $8.5 billion per year to the drug companies.
But this new study says that one-third of the women taking these drugs are still at high risk for fractures.
Now here’s what you have to understand. The study was done by a subsidiary of Merck & Co. They make Fosamax, one of the biggest bone drugs. So instead of saying the drugs don’t work ...
Source: Al Sears, MD Natural Remedies - September 6, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Health Source Type: news
Zoledronic acid protects against bone density loss caused by antiretrovirals
Administering 5 mg of zoledronic acid at the start of antiretroviral therapy to HIV-infected patients who have never previously undergone ART can significantly decrease the risk of bone density loss.... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 30, 2016 Category: Endocrinology Source Type: news
Progeria triple-therapy findings ‘disappointing’
Pravastatin and zoledronic acid provide no additional clinically relevant benefit to lonafarnib monotherapy for patients with Hutchinson-Gilford progeria syndrome, study findings indicate. (Source: MedWire News)
Source: MedWire News - July 12, 2016 Category: Consumer Health News Tags: Cardiology Source Type: news
Single-Dose Drug Decreases Bone Loss in Newly Treated HIVSingle-Dose Drug Decreases Bone Loss in Newly Treated HIV
A single dose of zoledronic acid given at the start of ART decreases bone loss over the course of 48 weeks in HIV, according to a small, single-center, proof-of-concept study. Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - May 23, 2016 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
Zoledronic acid improved bone health in patients with osteoporosis
Use of zoledronic acid for the treatment of osteoporosis enhanced bone mineral density and reduced bone turnover in patients, according to results published in the journal Orthopedics.
Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 4, 2016 Category: Endocrinology Source Type: news
Zometa (Zoledronic Acid for Inj) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 2, 2016 Category: Drugs & Pharmacology Source Type: news
Reclast (Zoledronic Acid Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 25, 2016 Category: Drugs & Pharmacology Source Type: news
Zolodrenic acid can prevent early bone loss in HIV patients on antiretroviral therapy
(Emory Health Sciences) A single dose of the drug zoledronic acid was found to inhibit the bone loss that is common in HIV-infected patients and that is increased during the first two years of treatment with antiretroviral therapy. Bone loss also leads to a higher rate of fracture in HIV-infected individuals. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 23, 2016 Category: Global & Universal Source Type: news
Adverse events after paediatric zoledronic acid infusion common
Although acute adverse events associated with zoledronic acid infusion in paediatric patients with bone disorders are common, they mainly occur after the initial infusion and are generally mild and easily managed, according to recent findings published in the Journal of Clinical Endocrinology and Metabolism. Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 14, 2015 Category: Endocrinology Source Type: news
Complications of New MedicationsComplications of New Medications
This case of jaw osteonecrosis highlights a potential adverse effect of zoledronic acid, commonly prescribed for osteoporosis. Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 29, 2015 Category: Consumer Health News Tags: Emergency Medicine Journal Article Source Type: news
Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial - Greenspan SL, Perera S, Ferchak MA, Nace DA, Resnick NM.
IMPORTANCE: Eighty-five percent of institutionalized elderly people have osteoporosis and bone fracture rates 8 to 9 times higher than rates observed among community-dwelling elderly people. Nevertheless, most of these persons are left untreated and are ex... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - April 17, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news
Zoledronic Acid Ups BMD in Seniors Without Cutting FracturesZoledronic Acid Ups BMD in Seniors Without Cutting Fractures
A single infusion of zoledronic acid improved BMD over the course of 2 years in frail institutionalized elderly women with osteoporosis, but this improvement did not translate to better outcomes. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 15, 2015 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
Zoledronic Acid Improves Bone Density in Frail Elders with Osteoporosis (FREE)
By Jenni Whalen
Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
Frail older women with osteoporosis may benefit from one dose of zoledronic acid (Reclast) during a 2-year period, according to a study in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 14, 2015 Category: Primary Care Source Type: news
Bone mineral density improved in frail elderly women treated with zoledronic acid
A single intravenous dose of the osteoporosis drug zoledronic acid improved bone mineral density in a group of frail elderly women living in nursing homes and long-term-care facilities. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 13, 2015 Category: Science Source Type: news
